BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27909742)

  • 1. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
    Said MM; Bosland MC
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
    Shibuya S; Xia Z; Sugimoto M; Ueda N; Haba R; Kakehi Y
    Urology; 2014 Mar; 83(3):528-34. PubMed ID: 24581515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
    Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
    Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
    Maeba S; Ichiyama T; Ueno Y; Makata H; Matsubara T; Furukawa S
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):670-4. PubMed ID: 15984600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
    Al-Amran FG; Hadi NR; Hashim AM
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
    Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
    Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
    Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
    Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
    Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate.
    Harris MT; Feldberg RS; Lau KM; Lazarus NH; Cochrane DE
    Prostate; 2000 Jun; 44(1):19-25. PubMed ID: 10861753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
    Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
    Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
    Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
    Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.
    Saad MA; Abdelsalam RM; Kenawy SA; Attia AS
    Neurochem Res; 2015 Jan; 40(1):139-50. PubMed ID: 25403620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
    Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z
    Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montelukast protects against renal ischemia/reperfusion injury in rats.
    Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
    Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.
    Holma R; Salmenperä P; Riutta A; Virtanen I; Korpela R; Vapaatalo H
    Eur J Pharmacol; 2001 Oct; 429(1-3):309-18. PubMed ID: 11698051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
    Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
    Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
    Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats.
    Holma R; Salmenperä P; Virtanen I; Vapaatalo H; Korpela R
    J Physiol Pharmacol; 2007 Sep; 58(3):455-67. PubMed ID: 17928642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
    Zhou C; Shi X; Huang H; Zhu Y; Wu Y
    Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.